期刊文献+

Galectin-3和VEGF在宫颈病变组织中的表达及意义 被引量:10

Expression and Significance of Galectin-3 and VEGF in Cervical Lesions
下载PDF
导出
摘要 目的探讨半乳糖凝集素-3(Galectin-3)和血管内皮生长因子(VEGF)蛋白的表达水平与不同病理改变的宫颈组织的关系,两者与宫颈癌临床病理特征的关系及两者的相关性。方法采用免疫组织化学S-P法,分别检测Galectin-3和VEGF在慢性宫颈炎(宫颈炎组,15例)、宫颈上皮内瘤变(CIN)(CIN组,30例)及宫颈癌(宫颈癌组,78例)中的表达;分析Galectin-3和VEGF的表达与宫颈癌临床病理特征的关系。结果宫颈炎组、CIN组、宫颈癌组Galectin-3蛋白表达阳性率分别为26.7%、73.3%、87.2%。CIN组Galectin-3蛋白表达阳性率明显高于宫颈炎组(P<0.05),宫颈癌组Galectin-3蛋白表达阳性率明显高于CIN组(P<0.05)。宫颈炎组、CIN组、宫颈癌组VEGF蛋白表达阳性率分别为33.3%、60.0%、76.9%,宫颈癌组VEGF蛋白表达阳性率明显高于宫颈炎组(P<0.005)。Galectin-3和VEGF的表达与年龄、病理学类型、淋巴结转移无关(P>0.05),而与宫颈癌宫颈间质浸润深度、肿瘤直径等有关(P<0.05)。Galectin-3与VEGF在宫颈癌中的表达呈正相关性(rs=0.684,P<0.05)。结论 Galectin-3和VEGF在CIN和宫颈癌组织呈高表达;两者可能参与了宫颈癌的发生和进展;与宫颈癌宫颈间质浸润深度、肿瘤直径等相关;两者在宫颈癌组织中存在共表达;可作为宫颈癌组织中的生物标志物。 Objective To explore the relationship between the expression levels of galectin-3 and vascular endothelial growth factor(VEGF)protein and pathological changes in cervical tis-sue,and to investigate the relationship between the expression of galectin-3 and VEGF and clini-cal pathological characteristics of cervical cancer.Methods The expression of galectin-3 and VEGF was detected by immunohistochemical S-P method in 15 cases of chronic cervicitis,30 cases of cervical intraepithelial neoplasia(CIN)and 78 cases of cervical cancer.The relationship between the expression of galectin-3 and VEGF and clinicopathological features of cervical cancer was ana-lyzed.Results The positive expression rate of galectin-3 protein was 26.7%,73.3% and 87.2%in cervicitis group,CIN group and cervical cancer group,respectively.Compared with CIN group, galectin-3 expression significantly decreased in cervicitis group,but obviously increase in cervical cancer group(P 〈0.05).The positive expression rate of VEGF protein was 33.3%,60.0% and&amp;nbsp;76.9% in cervicitis group,CIN group and cervical cancer group,respectively.Compared with cer-vicitis group,VEGF expression significantly increased in cervical cancer group(P 〈0.005).The expression of galectin-3 and VEGF was not correlated with the age,pathological type and lymph node metastasis(P 〈0.05),but was related to cervical stromal infiltration depth and tumor diame-ter in cervical cancer(P 〈0.05).In addition,the expression of galectin-3 was positively correlated with the expression of VEGF in cervical cancer(rs =0.684,P 〈0.05).Conclusion Both galectin-3 and VEGF are expressed in CIN and cervical cancer tissues and may be involved in the occurrence and progression of cervical cancer.The expression galectin-3 and VEGF is related to cervical stro-mal infiltration depth and tumor diameter in cervical cancer.Therefore,galectin-3 and VEGF can be used as the biomarkers of cervical cancer.
出处 《南昌大学学报(医学版)》 CAS 2014年第3期13-17,F0003,共6页 Journal of Nanchang University:Medical Sciences
关键词 半乳糖凝集素-3 血管内皮生长因子 宫颈癌 免疫组织化学 分子靶向治疗 GALECTIN-3 vascular endothelial growth factor cervical cancer immunohistochemistry molecular targeted therapy
  • 相关文献

参考文献11

二级参考文献189

  • 1唐惕凡,丁果元,刘庆田,向华林.冠心病患者心经心包经原穴体表病理反应的观察[J].湖南中医学院学报,1995,15(1):58-60. 被引量:16
  • 2雷彩霞,张炜,孙晓炜,杜国平,王丽,刘银坤.Galectin-3表达抑制对子宫内膜上皮细胞生长周期和黏附性的影响[J].复旦学报(医学版),2007,34(2):169-175. 被引量:12
  • 3程变巧,姜泊,包杰.Galectin-3 shRNA载体的构建表达及其对大肠癌细胞lovo增殖率的影响[J].第四军医大学学报,2007,28(11):1014-1017. 被引量:3
  • 4Su JL Shih JY,Yen ML,et al.Cyclooxygenase-2 induces EPI-and HER-2/Neu-dependent VasCular endothelial growth factor-C upregulation:a novel mechanism of lymphangiogenesis in lung adenocarcinoma[J].Cancer Res,2004,64(2):554-564.
  • 5Saldivar JS,Lopez D,Feldrnan RA,et al.COX-2 overexpression as a biomarker of early cervical carcinogenesis:a pilot study[J].Gynecol Oneol,2007,107(1 Suppl 1):S155-162.
  • 6Smith WL,DcWitt DL Garavito RM.Cyclooxygenases:structural,cellular,and molecular biology[J].Annu Rev Biochem,2000,69:145-182.
  • 7Williams CS,Tsujii M,Reese J,et al.Host eyelooxygenase-2 Modulated carcinoma growth[J].J Clin Invest,2000,105(11):1589-1594.
  • 8Makinen T,Veikkola T,Mustjoki S,et al.Isolated lymphatic endothelial cells transduce growth,survival and migratory signals via the VEGF-C/D receptor VEGFR-3[J].EMBO J,2001,20(17):4762-4773.
  • 9Dai Y; Zhang x,Peng Y,et al.The expression of cyclooxysenase-2,VEGF and PGs in CIN and cervical carcinoma[J].Gynecol Oneol,2005,97(1):96-103.
  • 10Gaffney DK,Holden J,Davis M,et al.Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy[J].Int J Radiat Oncol Biol Phys,2001,49(5):1213-1217.

共引文献52

同被引文献115

  • 1杨志明,伍晓汀,何涛.Galectin-3与肿瘤转移[J].中国普外基础与临床杂志,2005,12(3):310-313. 被引量:21
  • 2杜趁香,王焱,何涛,邢鲁奇,米建强,阎慧娟.宫颈病变组织中P-Akt、NF-κB的表达变化及意义[J].山东医药,2010,50(50):91-92. 被引量:1
  • 3孙晓炜,张炜,周剑萍,王丽.galectin-3在子宫内膜异位症患者在位内膜中的表达及意义[J].中国免疫学杂志,2007,23(2):138-141. 被引量:6
  • 4赵健,宋学红,耿力,夏蓓,孙红,李柱南,廖秦平.重组人干扰素α-2b凝胶治疗慢性宫颈炎疗效观察[J].中国实用妇科与产科杂志,2007,23(8):616-618. 被引量:45
  • 5刘嵘,濮德敏,程铭,尹伶,李天.Galectin-3蛋白在宫颈病变组织中的表达及意义[J].中国妇幼保健,2007,22(28):4007-4010. 被引量:5
  • 6Nangia-Makker P, Raz T, Tait L, et al. Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers. Cancer Res, 2007, 67 (24) : 11760-11768.
  • 7Yu F, Finley RL Jr, Raz A, et al. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J Biol Chem, 2002, 277 (18) : 15819-15827.
  • 8de Matos PS, Ferreira AP, de Oliveira Facuri F, et al. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology, 2005, 47 (4) : 391-401.
  • 9Brustmann H. Epidermal growth factor receptor expression in serous ovarian carcinoma :an immunohistochemical study with galectin-3 and cyclin D1 and outcome. Int J Gynecol Pathol, 2008, 27 (3) : 380-389.
  • 10Kimura H, Kato H, Tanaka N, et al. Preoperative serum vascular endothelial growth factor (VEUF) levels predict recurrence in patients with esophageal cancer. Anticancer Res, 2008, 28 (1A) : 165-169.

引证文献10

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部